230301-82-3Relevant articles and documents
SPIROCYCLIC TETRAHYDROQUINAZOLINES
-
Paragraph 0722; 0731-0733, (2021/07/17)
Provided are compounds represented by Formula I, wherein R3, A, A1, A2, A3, E, E1, E2, L, Q, Z, and (aa) are as defined in the specification, and the pharmaceutically acceptable salts and solvates thereof. Compounds of Formula (I) are KRAS inhibitors and are thus useful to treat cancer and other diseases.
Tetrahydrobenzindole derivatives
-
, (2008/06/13)
Compounds containing tetrahydrobenzindole which bind to serotonin receptor and are useful in treatment or prevention of disease induced by abnormality of central peripheral serotonin controlling functions.